Beta Therapeutics Pty. Ltd.
http://www.betatherapeutics.com.au/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Beta Therapeutics Pty. Ltd.
Start-Up Spotlight: Synchron Hopes To Make Brain Interface A Reality Without Surgery
Synchron has high hopes that after successfully implanting the first minimally invasive neural brain-computer interface device in a human, it will eventually be able to give a "voice" to patients, including paralyzed individuals, who are unable to communicate. The company is conducting clinical trials and is hoping to use the data to apply for US FDA approval of the Stentrode device.
Deal Watch: Boehringer, Epizyme Team Up To Develop Epigenetic Cancer Therapies
BI and Epizyme’s collaboration will focus on developing novel cancer drugs targeting helicase and HAT enzyme dysregulation. MorphoSys and I-Mab will partner on developing an IO therapy targeting C5aR.
First Endovascular Neural Interface Eyed By New Firm Synchron
The company launched in Silicon Valley on April 21 with plans to develop a device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
First Endovascular Neural Interface Eyed By New Firm Synchron
The company launched in Silicon Valley on April 21 with plans to develop a device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice